Flagship Ventures Fund 2007, L.P.
Insider CIK 1508052 · TTPH 10% owner · BGMD 10% owner · AGIO 10% owner · SELB 10% owner · RCPT 10% owner · EBIO 10% owner · MCRB 10% owner · AXLA 10% owner · KLDO 10% owner · TMDX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group, Inc. | J Other | 2019-10-29 | 2019-10-31 | 1,469,173 | — | $0 | 0 | SEC↗ |
| TMDX TransMedics Group, Inc. | J Other | 2019-10-29 | 2019-10-31 | 1,061,102 | — | $0 | 0 | SEC↗ |
| TMDX TransMedics Group, Inc. | J Other | 2019-10-29 | 2019-10-31 | 61,537 | — | $0 | 0 | SEC↗ |
| TMDX TransMedics Group, Inc. | J Other | 2019-10-29 | 2019-10-31 | 248,379 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 895,255 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 89,525 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 358,102 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 151,643 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 617,914 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 222,506 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 1,005,413 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 1,384,615 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 4,153,847 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 928,074 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 386,697 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 751,691 | — | $0 | 1,430,301 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2019-05-13 | 2019-05-15 | 500,000 | $20.00 | $10.00M | 986,023 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 486,023 | — | $0 | 486,023 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 48,602 | — | $0 | 676,752 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 194,409 | — | $0 | 3,288,780 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 82,324 | — | $0 | 628,150 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 335,457 | — | $0 | 3,094,371 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 120,795 | — | $0 | 1,761,029 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 2,255,074 | — | $0 | 2,255,074 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 503,840 | — | $0 | 2,758,914 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 209,933 | — | $0 | 1,640,234 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 545,826 | — | $0 | 545,826 | SEC↗ |
| TMDX TransMedics Group, Inc. | C Conversion deriv | 2019-05-06 | 2019-05-06 | 2,000,000 | — | $0 | 0 | SEC↗ |
| TMDX TransMedics Group, Inc. | C Conversion deriv | 2019-05-06 | 2019-05-06 | 992,110 | — | $0 | 0 | SEC↗ |
| TMDX TransMedics Group, Inc. | C Conversion deriv | 2019-05-06 | 2019-05-06 | 1,400,000 | — | $0 | 0 | SEC↗ |
| TMDX TransMedics Group, Inc. | C Conversion deriv | 2019-05-06 | 2019-05-06 | 1,257,465 | — | $0 | 0 | SEC↗ |
| TMDX TransMedics Group, Inc. | C Conversion deriv | 2019-05-06 | 2019-05-06 | 600,000 | — | $0 | 0 | SEC↗ |
| TMDX TransMedics Group, Inc. | C Conversion deriv | 2019-05-06 | 2019-05-06 | 450,958 | — | $0 | 0 | SEC↗ |
| TMDX TransMedics Group, Inc. | C Conversion deriv | 2019-05-06 | 2019-05-06 | 1,682,665 | — | $0 | 0 | SEC↗ |
| TMDX TransMedics Group, Inc. | C Conversion | 2019-05-06 | 2019-05-06 | 1,254,888 | — | $0 | 1,469,173 | SEC↗ |
| TMDX TransMedics Group, Inc. | J Other | 2019-05-06 | 2019-05-06 | 214,285 | — | $0 | 214,285 | SEC↗ |
| TMDX TransMedics Group, Inc. | J Other | 2019-05-06 | 2019-05-06 | 940,579 | — | $0 | 0 | SEC↗ |
| TMDX TransMedics Group, Inc. | C Conversion | 2019-05-06 | 2019-05-06 | 792,366 | — | $0 | 1,061,102 | SEC↗ |
| TMDX TransMedics Group, Inc. | J Other | 2019-05-06 | 2019-05-06 | 750,000 | — | $0 | 0 | SEC↗ |
| TMDX TransMedics Group, Inc. | J Other | 2019-05-06 | 2019-05-06 | 268,736 | — | $0 | 268,736 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 347,173 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 1,331,816 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 562,407 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 665,908 | — | $0 | 665,908 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 173,586 | — | $0 | 216,451 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 281,203 | — | $0 | 947,111 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-23 | 2016-09-26 | 41,178 | $3.10 | $127.7K | 426,885 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-23 | 2016-09-26 | 3,118 | $3.16 | $9.9K | 117,080 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-23 | 2016-09-26 | 12,482 | $3.16 | $39.4K | 468,063 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-23 | 2016-09-26 | 10,293 | $3.10 | $31.9K | 106,787 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-22 | 2016-09-26 | 188,367 | $3.17 | $597.1K | 480,545 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-22 | 2016-09-26 | 47,090 | $3.17 | $149.3K | 120,198 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-22 | 2016-09-26 | 28,163 | $3.18 | $89.6K | 167,288 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-22 | 2016-09-26 | 112,731 | $3.18 | $358.5K | 668,912 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-21 | 2016-09-21 | 258,214 | $3.75 | $968.3K | 781,643 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-21 | 2016-09-21 | 64,509 | $3.75 | $241.9K | 195,451 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-20 | 2016-09-21 | 10,778 | $3.39 | $36.5K | 259,960 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-20 | 2016-09-21 | 43,139 | $3.39 | $146.2K | 1,039,857 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-19 | 2016-09-21 | 1,939 | $3.31 | $6.4K | 270,738 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-19 | 2016-09-21 | 7,761 | $3.31 | $25.7K | 1,082,996 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-15 | 2016-09-16 | 536 | $4.16 | $2.2K | 272,677 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-15 | 2016-09-16 | 2,145 | $4.16 | $8.9K | 1,090,757 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-14 | 2016-09-16 | 8,802 | $4.18 | $36.8K | 273,213 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-14 | 2016-09-16 | 35,209 | $4.18 | $147.2K | 1,092,902 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-07 | 2016-09-08 | 32,597 | $4.51 | $147.0K | 1,128,111 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-07 | 2016-09-08 | 8,145 | $4.51 | $36.7K | 282,015 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-07 | 2016-09-08 | 52,985 | $4.51 | $239.0K | 1,833,802 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-06 | 2016-09-08 | 12,441 | $4.63 | $57.6K | 1,160,708 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-06 | 2016-09-08 | 20,221 | $4.63 | $93.6K | 1,886,787 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-09-06 | 2016-09-08 | 3,108 | $4.63 | $14.4K | 290,160 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 318,752 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 631,458 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 235,042 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 241,718 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 125,008 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion | 2016-06-27 | 2016-06-29 | 241,718 | — | $0 | 1,458,085 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion | 2016-06-27 | 2016-06-29 | 235,042 | — | $0 | 1,216,367 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion | 2016-06-27 | 2016-06-29 | 193,777 | — | $0 | 1,651,862 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion | 2016-06-27 | 2016-06-29 | 318,752 | — | $0 | 349,867 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion | 2016-06-27 | 2016-06-29 | 631,458 | — | $0 | 981,325 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2016-05-25 | 2016-05-27 | 800,000 | — | $0 | 8,022,420 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-25 | 2016-05-27 | 599,297 | $27.60 | $16.54M | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-25 | 2016-05-27 | 80,141 | $27.60 | $2.21M | 1,925,462 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-25 | 2016-05-27 | 320,562 | $27.60 | $8.85M | 2,734,994 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2016-05-25 | 2016-05-27 | 33,514 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2016-05-25 | 2016-05-27 | 7 | — | $0 | 33,514 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2016-05-25 | 2016-05-27 | 33,507 | — | $0 | 33,514 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2016-05-25 | 2016-05-27 | 200,000 | — | $0 | 1,925,462 | SEC↗ |
| BGMD BG Medicine, Inc. | C Conversion deriv | 2015-07-14 | 2015-07-16 | 13,553 | — | $0 | 13,553 | SEC↗ |
| BGMD BG Medicine, Inc. | C Conversion deriv | 2015-07-14 | 2015-07-16 | 725,725 | — | $0 | 909,696 | SEC↗ |
| BGMD BG Medicine, Inc. | J Other deriv | 2015-07-14 | 2015-07-16 | 183,971 | — | $0 | 183,971 | SEC↗ |
| BGMD BG Medicine, Inc. | C Conversion deriv | 2015-07-14 | 2015-07-16 | 397,072 | — | $0 | 497,729 | SEC↗ |
| BGMD BG Medicine, Inc. | J Other deriv | 2015-07-14 | 2015-07-16 | 100,657 | — | $0 | 100,657 | SEC↗ |
| BGMD BG Medicine, Inc. | P Buy deriv | 2015-07-14 | 2015-07-16 | 0 | $1.70 | $0 | 0 | SEC↗ |
| BGMD BG Medicine, Inc. | J Other deriv | 2015-07-14 | 2015-07-16 | 0 | — | $0 | 0 | SEC↗ |
| BGMD BG Medicine, Inc. | C Conversion deriv | 2015-07-14 | 2015-07-16 | 0 | — | $0 | 0 | SEC↗ |
| BGMD BG Medicine, Inc. | C Conversion deriv | 2015-07-14 | 2015-07-16 | 0 | — | $0 | 0 | SEC↗ |
| BGMD BG Medicine, Inc. | P Buy deriv | 2015-07-14 | 2015-07-16 | 0 | $1.70 | $0 | 0 | SEC↗ |
| BGMD BG Medicine, Inc. | P Buy deriv | 2015-07-14 | 2015-07-16 | 53,465 | $1.70 | $90.9K | 67,018 | SEC↗ |
| BGMD BG Medicine, Inc. | C Conversion deriv | 2015-07-14 | 2015-07-16 | 0 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion deriv | 2015-06-26 | 2015-06-29 | 898,877 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion deriv | 2015-06-26 | 2015-06-29 | 6,105,362 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion deriv | 2015-06-26 | 2015-06-29 | 1,526,338 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion deriv | 2015-06-26 | 2015-06-29 | 454,546 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion deriv | 2015-06-26 | 2015-06-29 | 1,818,181 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion deriv | 2015-06-26 | 2015-06-29 | 224,719 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion deriv | 2015-06-26 | 2015-06-29 | 599,297 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion | 2015-06-26 | 2015-06-29 | 599,297 | — | $0 | 599,297 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion | 2015-06-26 | 2015-06-29 | 2,205,603 | — | $0 | 2,205,603 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | C Conversion | 2015-06-26 | 2015-06-29 | 8,822,420 | — | $0 | 8,822,420 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2015-06-25 | 2015-06-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | J Other | 2014-06-23 | 2014-06-25 | 1,930,369 | — | $0 | 1,930,369 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 1,050,000 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 1,680,213 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 420,053 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 4,200,000 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 9,000,000 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion | 2014-02-11 | 2014-02-13 | 926,017 | — | $0 | 1,041,427 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion | 2014-02-11 | 2014-02-13 | 1,417,323 | — | $0 | 1,692,913 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion | 2014-02-11 | 2014-02-13 | 231,504 | — | $0 | 260,356 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | P Buy | 2014-02-11 | 2014-02-13 | 32,912 | $10.00 | $329.1K | 293,268 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | P Buy | 2014-02-11 | 2014-02-13 | 214,095 | $10.00 | $2.14M | 1,907,008 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | P Buy | 2014-02-11 | 2014-02-13 | 131,722 | $10.00 | $1.32M | 1,173,149 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2013-11-18 | 2013-11-18 | 20,300 | $24.09 | $489.0K | 1,693,551 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2013-11-15 | 2013-11-18 | 54,000 | $24.20 | $1.31M | 1,714,755 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2013-11-15 | 2013-11-18 | 904 | $25.10 | $22.7K | 1,713,851 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2013-11-14 | 2013-11-18 | 155,583 | $25.03 | $3.89M | 1,768,755 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | C Conversion deriv | 2013-07-29 | 2013-07-31 | 617,031 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | C Conversion deriv | 2013-07-29 | 2013-07-31 | 10,000,000 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | C Conversion | 2013-07-29 | 2013-07-31 | 3,860,738 | — | $0 | 3,860,738 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-05-14 | 8,640,289 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-05-14 | 4,131,552 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | P Buy | 2013-05-14 | 2013-05-14 | 107,142 | $14.00 | $1.50M | 1,924,339 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-05-14 | 1,152,039 | $5.25 | $6.05M | 1,266,324 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-05-14 | 550,873 | $7.73 | $4.26M | 1,817,197 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 2,090,000 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 2,726,088 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 11,422,045 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 19,544,924 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 9,626,604 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | P Buy | 2013-03-25 | 2013-03-27 | 491,824 | $7.00 | $3.44M | 1,165,786 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 673,962 | — | $0 | 673,962 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 331,953 | — | $0 | 891,887 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 393,863 | — | $0 | 559,934 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 94,003 | — | $0 | 166,071 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 72,068 | — | $0 | 72,068 | SEC↗ |